Singapore: With an agenda to expand its footprint in the emerging markets, Japan's Eisai Pharma is launching its novel a...
Singapore: Australia-based Prana Biotechnology is to make senior appointments as it prepares to advance its key drug to ...
Singapore: Oramed Pharmaceuticals initiated patient recruitment for a new clinical trial of its orally ingestible insuli...
Singapore: A new study by GlobalData has revealed that New Zealand's Pharmaceutical Management Agency's (PHARMAC) is emp...
Singapore: Australia's Allied Healthcare is progressing in the regulatory process for obtaining European CE Mark approva...
Singapore: A collaborative research effort at Duke University Medical Center and Rockefeller University has pinpointed t...
Singapore: The US FDA's Pulmonary-Allergy Drugs Advisory Committee (PADAC) has approved GlaxoSmithKline (GSK) and Therav...
Singapore: Bayer has received Japan's approval for Stivarga indicated for the treatment of patients suffering from gastr...
Singapore: Theravance and Alfa Wassermann entered into an exclusive development and commercialization agreement in cert...
Singapore: Epilepsy Foundation of US has called on the Drug Enforcement Administration (DEA), US, to revise its process ...
Singapore: WHO and the Global Fund to Fight AIDS, TB and Malaria said that strains of tuberculosis with resistance to mu...
Singapore: Daiichi Sankyo has launched TaNeDS (Take a New challenge for Drug diScovery) collaborative drug discovery pro...
Singapore: At the recent international BIO Conference in Philadelphia, Queensland's Premier Ms Annastacia Palaszczuk ann...
Singapore: Australia-based Patrys, a clinical stage biotechnology company, has received confirmation of Orphan Medicinal...
Singapore: Europe-based Galapagos and AbbVie entered into a global alliance to discover, develop and commercialize novel...
Singapore: Mylan signed a new agreement between its subsidiary Mylan Laboratories and Gilead Sciences. According top thi...
Even as most emerging economies in Asia Pacific are trying to grab a foothold in the global biopharma space, China has e...
Singapore: Anaphore changed its corporate name to RuiYi. As part of the company's shift in strategy to the R&D of n...
